rs11235972 — UCP3

Intronic UCP3 variant associated with skeletal muscle fat oxidation capacity, hand grip strength, and survival in aging populations

See your personal result for UCP3

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

UCP3 rs11235972 — Skeletal Muscle Fat Handling and the Aging Engine

UCP3 (uncoupling protein 3)11 UCP3 (uncoupling protein 3)
A mitochondrial inner membrane protein expressed predominantly in skeletal muscle and, to a lesser extent, brown adipose tissue has long been debated as a thermogenic protein. The current consensus, however, points to a different primary role: protecting skeletal muscle mitochondria from the toxic accumulation of excess fatty acids. rs11235972 is an intronic variant in UCP3 on chromosome 11 that sits in strong linkage disequilibrium with the functional promoter variant rs1800849 — making it a reliable tag SNP for the functional haplotype. Studies have linked the A allele of rs11235972 to lower hand grip strength and higher mortality in aging cohorts, suggesting that reduced UCP3 function impairs the muscle's ability to handle fat loads as we age.

The Mechanism

UCP3 operates at the junction of fat utilization and mitochondrial health. When skeletal muscle cells receive more fatty acids than their oxidative machinery can immediately process, excess fatty acid anions and lipid peroxides build up inside the mitochondrial matrix — a condition called lipotoxicity22 lipotoxicity
Accumulation of lipid intermediates that damage mitochondrial membranes, impair electron transport, and generate reactive oxygen species. UCP3 exports these excess fatty acid anions out of the matrix, protecting the mitochondrial membranes and electron transport chain. It also appears to limit reactive oxygen species (ROS)33 reactive oxygen species (ROS)
Unstable oxygen-containing molecules produced as a byproduct of energy metabolism that damage proteins, lipids, and DNA when they accumulate production during fatty acid oxidation.

rs11235972 is located within intron 5 of UCP3 and does not alter the protein directly. Its biological effect likely operates through the haplotype it tags: the functional promoter SNP rs1800849 (in D'=0.97 LD) controls UCP3 transcription, with the T allele of rs1800849 (tagging the common G allele of rs11235972) driving higher UCP3 expression in skeletal muscle. Individuals carrying the A allele of rs11235972 are thus more likely to express lower UCP3 protein levels, impairing the muscle's lipid-handling capacity.

The Evidence

The most direct evidence comes from Dato et al. 201244 Dato et al. 2012
Two Danish cohorts: middle-aged N=708 and oldest-old N=908, which found that the A allele at rs11235972 was associated with lower hand grip strength at both the single-SNP and haplotype level — consistently across both cohort ages. Beyond grip strength, A allele carriers showed higher 10-year mortality rates, suggesting that impaired UCP3 function in skeletal muscle affects functional reserve during aging. Hand grip strength is a robust biomarker of overall muscle quality and a predictor of all-cause mortality in older adults.

A complementary line of evidence comes from the UCP3 promoter variant rs1800849 (in near-perfect LD with rs11235972): the Montesanto et al. 201155 Montesanto et al. 2011
Large aged Italian cohort, ages 65-105 cohort found that the T allele of rs1800849 (corresponding to higher UCP3 expression) was associated with superior grip strength, and the authors concluded that efficient uncoupling activity has a protective effect on aging muscle by slowing mitochondrial decay.

At the mechanistic level, Nabben et al. 201166 Nabben et al. 2011
UCP3 knockout mice on 8-week and 26-week high-fat diets demonstrated that UCP3-null mice develop elevated mitochondrial ROS production within 8 weeks and measurably reduced mitochondrial function after 26 weeks of high-fat diet — establishing a causal role for UCP3 in protecting against lipid-induced mitochondrial dysfunction. Schrauwen et al. 200677 Schrauwen et al. 2006
Comprehensive mechanistic review noted that low UCP3 expression is a consistent feature of insulin-resistant and type 2 diabetic muscle, linking impaired fatty acid handling to downstream metabolic disease.

A Brazilian pediatric case-control study (Fortes et al. 202388 Fortes et al. 2023
225 children, 123 obese) found rs11235972 in a two-SNP haplotype block (with rs1800849) that showed linkage disequilibrium with adverse lipid profiles. While the effect size for rs11235972 individually was not isolated, the haplotype data supports its role in lipid metabolism across the lifespan.

Practical Actions

For A allele carriers — particularly those with the AA genotype — the impaired UCP3 activity means skeletal muscle mitochondria are less efficient at exporting excess fatty acids and controlling ROS during high-fat conditions. The key strategies involve supporting mitochondrial function directly, managing the fatty acid load that reaches muscle cells, and monitoring for markers of mitochondrial oxidative stress.

High-fat dietary patterns over the long term impose the greatest burden on UCP3-dependent protection. Shifting toward fat sources that are more readily oxidized (e.g., medium-chain fats and omega-3 polyunsaturates) rather than long-chain saturated fats reduces the lipotoxic load. Ubiquinol (the reduced form of coenzyme Q10) supports the electron transport chain efficiency and reduces upstream ROS production — particularly relevant when UCP3's ROS-limiting function is impaired.

Resistance and endurance training both upregulate UCP3 expression in skeletal muscle, providing a compensatory mechanism. This effect is especially important for A allele carriers: training-induced UCP3 upregulation may partially compensate for genetically lower basal expression.

Interactions

rs11235972 sits in strong LD (D'=0.97) with rs1800849, the promoter variant that directly controls UCP3 transcription. Most published studies on UCP3 functional effects have examined rs1800849; rs11235972 largely captures the same haplotype signal. Compound heterozygosity with rs1800849 (when the two are not in perfect LD in a specific individual) may have independent effects.

UCP3 operates in the same mitochondrial pathway as UCP1 (brown fat thermogenesis) and UCP2 (broad tissue expression). Variants in UCP2 (notably rs659366) that reduce mitochondrial uncoupling could theoretically compound with UCP3 A allele effects on overall mitochondrial ROS protection in skeletal muscle. No published compound interaction studies exist for rs11235972 × UCP2 variants, but the mechanistic rationale is strong given their shared function.

PGC-1α (PPARGC1A, rs8192678) is the master regulator of mitochondrial biogenesis and upregulates UCP3 expression in response to exercise; individuals with combined low PGC-1α function and low UCP3 expression may have compounded impairment in exercise-induced mitochondrial adaptation.

Nutrient Interactions

fatty acids altered_metabolism
coenzyme Q10 increased_need

Genotype Interpretations

What each possible genotype means for this variant.

GG Standard Fat Handling Normal

Normal UCP3 function — standard skeletal muscle fat oxidation

You carry two copies of the G allele at rs11235972, the most common genotype in most populations. This genotype tags the UCP3 haplotype associated with normal UCP3 expression in skeletal muscle, meaning your muscle mitochondria can efficiently export excess fatty acid anions and limit reactive oxygen species production during fat metabolism. Approximately 57% of people share this genotype globally. No specific action is required.

AG Mildly Reduced Fat Handling Intermediate

One A allele — modestly reduced UCP3 activity in skeletal muscle

UCP3 in skeletal muscle exports excess fatty acid anions from the mitochondrial matrix, protecting against lipotoxicity and limiting reactive oxygen species (ROS) during fat oxidation. With one A allele, basal UCP3 expression is modestly reduced, meaning your muscle mitochondria have a somewhat lower capacity to handle large fatty acid loads before oxidative stress accumulates. This becomes most relevant during sustained high-fat dietary exposures or during the muscle quality decline that accompanies normal aging.

The Danish cohort data (Dato et al. 2012) showed the A-allele effect on grip strength was consistent across both the middle-aged (N=708) and oldest-old (N=908) sub-cohorts, suggesting the impairment accrues gradually with age rather than appearing only in advanced old age.

AA Reduced Fat Handling Reduced

Two A alleles — meaningfully reduced UCP3 activity and elevated mitochondrial ROS risk

With two A alleles, UCP3 protein levels in skeletal muscle are expected to be at their genetically lowest — consistent with the expression data from mechanistic studies (Nabben et al. 2011) showing that UCP3 deficiency leads to elevated mitochondrial ROS at 8 weeks and measurable loss of mitochondrial respiratory function after 26 weeks on a high-fat diet. The clinical implication is a narrower margin before lipotoxic stress accumulates in skeletal muscle during sustained high-fat dietary exposures or during aging-related mitochondrial decline.

The grip-strength and mortality associations from Dato et al. 2012 were observed across both the A allele (heterozygous) and in those with lower grip strength in general — the homozygous AA state represents the high-risk tail of this distribution. This genotype warrants proactive mitochondrial support, with fatty acid composition management and targeted supplementation.

The rs1800849 promoter haplotype (D'=0.97 with rs11235972) is the functional driver: AA carriers here are very likely to also carry the promoter configuration associated with lowest UCP3 transcription.